CAS RN 138786-67-1
Pantoprazol-Natriumsalz, TRC
CAS: 138786-67-1 Summenformel: C16 H14 F2 N3 O4 S . Na Molekulargewicht (g/mol): 405.35 Synonym: Pantoprazole sodium,1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1),1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI),5-Difluoromethoxy-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole sodium salt,Controloc,Nolpaza,Pantecta,Pantoloc,Pantoprazole sodium salt,Protonix,Somac,Zurcal IUPAC-Name: Natrium; 5-(Difluoromethoxy)-2-[(3,4-Dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide SMILES: [Na+].COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[n-]2)c1OC
Pantoprazole sodium, MedChemExpress
MedChemExpress Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole sodium improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole sodium significantly increased tumor growth delay combined with Doxorubicin (HY-15142).